ACE and hydrops fetalis: This showed a 42% decrease in all-cause mortality with a fully complete combination of four HF agents [angiotensin-converting enzyme (ACE) inhibitors, beta-blocker, mineralocorticoid antagonist (MRA) with ivabradine] and 52% with ARNI added to beta-blocker and MRA therapy [43].